Edition:
United States

Theravance Inc (THRX.O)

THRX.O on Nasdaq

--USD
--
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
663,090
52-wk High
$16.62
52-wk Low
$6.36

THRX.O

Chart for THRX.O

About

Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $1,213.22
Shares Outstanding(Mil.): 111.20
Dividend: 0.25
Yield (%): 9.17

Financials

  THRX.O Industry Sector
P/E (TTM): 70.70 36.75 36.56
EPS (TTM): 0.15 -- --
ROI: 4.61 14.63 14.06
ROE: -- 15.43 14.98

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : GlobalData
$300.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.